Collaboration experience between hospitals and long-term care facilities for the care of COVID-19 patients
e202104053
Keywords:
Long-term care facilities, Nursing homes, Coordination, Health professionals, Elderly care, COVID-19Abstract
Background: The disease produced by SARS-CoV-2 has led to severe situations and mortality in elderly people. The objective of this study was to describe the collaboration between hospital professionals and nursing homes when applying preventive measures for the transmission of COVID-19 and in the assistance of institutionalized patients.
Methods: A descriptive study was carried out in 4 centers with information collected by researchers in two moments of the COVID-19 pandemic. The information collected was related to the resources and knowledge of infection prevention, details about face-to-face and telematic assistance from the hospital team, as well as material, drugs provided, and clinical results. The variables studied were described by means of percentages, absolute frequencies and ratios; statistical chi-square tests and McNemar’test were used.
Results: The study was conducted in 4 centers with a total of 640 residents and an initial occupancy between 62% and 85%. Differences were found regarding the ratio of staff and knowledge of preventive measures of the transmission of SARS-CoV-2 infection, which was improved in the second period of the study. The number of face-to-face visits (from 5 to 22) and telematic visits (between 42 and 109 patients) were different in the 4 nursing homes, as well as the material provided, adapted to the needs of each center. The percentage of infected patients ranged from 6.1% to 90.2%, and the accumulated mortality in the second period ranged from 15.38% to 38.35% of the residents at the beginning of the pandemic.
Conclusions: The collaboration between the professionals of healthcare centers and the hospital, adapted to the needs of each center, has allowed to improve the assistance to the residents and the coordination between the professionals, optimizing the available resources.
Downloads
References
WHO covid-19. Timeline. https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19. Consultado el 19 de octubre de 2020.
WHO COVID-19 Dashboard. https://covid19.who.int/. Consultado el 19 de octubre de 2020.
Epicentre. COVID-19 Epi Dashboard. https://reports.msf.net/public/covid19/. Consultado el 19 de octubre de 2020.
Actualization nº 133. Enfermedad por el coronavirus (COVID-19). 11.06.2020 (datos consolidados a las 14:00 horas del 11.06.2020). SITUACIÓN EN ESPAÑA. Ministerio de Sanidad, Consumo y Bienestar social. Madrid; 2020. Disponible en: https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_133_COVID-19.pdf. Consultado el 12 de junio de 2020.
Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, Wei S, Deng Y, Liu J, Liu HG, Ming Y, Hu Y. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J 2020;133 (9):1032–1038.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International 2020; 97: 829-838.
Centers for Disease Control and Prevention. Older Adults. Coronavirus Disease 2019 (COVID-19). Accessed April 4, 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html. Consultado el 6 de mayo de 2020.
Lithander FE, Neumann S, Tenison E, Lloyd K, Welsh TJ, Rodrigues JCL, Higgins JPT, Scourfield L, Christensen H, Haunton VJ, Henderson EJ. COVID-19 in older people: a rapid clinical review. Age Ageing. 2020 Jul 1;49(4):501-515.
Diarrhée, perte d’équilibre, modification du comportement, troubles sanguins sont potentiellement des signes avant-coureurs de l’infection respiratoire du Covid-19 chez la personne âgée fragile 2020 [Available from: https://sfgg.org/espace-presse/revue-de-presse/diarrhee-perte-dequilibre-modification-du-comportement-troubles-sanguins-sont-potentiellement-des-signes-avant-coureurs-de-linfection-respiratoire-du-covid-19-chez-la-person/. Consultado el 20 de agosto de 2020.
Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K et al. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):377-381.
Huhtinen E, Quinn E, Hess I, Najjar Z, Gupta L. Understanding barriers to effective management of influenza outbreaks by residential aged care facilities. Australas J Ageing. 2019;38(1):60–63.
Stanyon MR, Goldberg SE, Astle A, Griffiths A, Gordon AL. The competencies of Registered Nurses working in care homes: a modified Delphi study. Age Ageing. 2017;46(4):582–588.
Roxby AC, Greninger AL, Hatfield KM, Lynch JB, Dellit TH, James A et al. Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults — Seattle, Washington, 2020. MMWR Morb Mortal Wkly Rep 2020;69:416–418.
Secretaria General de Sanidad y Consumo. Dirección General de Salud Pública, Calidad e Innovación. Centro de coordinación de alertas y emergencias Sanitarias. Información científico-técnica. Enfermedad por coronavirus, COVID-19. Actualizado el 2 de junio de 2020. Disponble en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/ITCoronavirus.pdf. Consultado el 20 de agosto.
World Health Organization. Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19. Geneva, World Health Organisation, 2020. https://apps.who.int/iris/bitstream/handle/10665/331508/WHO- 2019-nCoV-IPC_long_term_care-2020.1-eng.pdf (accessed 28 March 2020). https://mc.manuscriptcentral.com/qjm6
British Geriatrics Society. Managing the COVID-19 pandemic in care homes. London, British Geriatrics Society, 2020. https://www.bgs.org.uk/resources/covid-19-managing-the-covid-19-pandemic-in-care-homes (accessed 28 March 2020).
Ministerio de Sanidad. Guía de prevención y control frente al COVID19 en residencias de mayores y otros centros de servicios sociales de carácter residencial . Versión de 24 de marzo de 2020. Disponible en: https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Residencias_y_centros_sociosanitarios_COVID-19.pdf. Consultado el 30 de marzo del 2020.
https://read.oecd-ilibrary.org/view/?ref=129_129658-l62d7lr66u&title=Testing-for-COVID19Away-to-lift-confinement-restrictions. Consultado el 10 de mayo del 2020.
Corregidor-Luna L, Hidalgo-Correas FJ, García-Díaz B. Gestión farmacéutica de la pandemia COVID-19 en un hospital mediano. Farm Hosp. 2020;44 (Supl 1):S11-6.
Cantudo-Cuenca MR, Cantudo-Cuenca MD, Muñoz-Cejudo BM, Cañizares Huarte-Mendicoa J. Variabilidad de la prestación farmacéutica a centros sociosanitarios residenciales desde los servicios de farmacia de hospital. Farm Hosp. 2019;43(3):82-6.
Comas-Herrera A, Zalakaín J, Litwin C, Hsu AT, Lane N, Fernández JL (2020) Mortality associated with COVID-19 outbreaks in care homes: early international evidence. Article in LTCcovid.org, International Long-Term Care Policy Network, CPEC-LSE, 21 May 2020.
McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. N Engl J Med 2020; 382:2005-2011.
Downloads
Published
How to Cite
License
Copyright (c) 2021 Pilar Sáez-López, Ana Belén Arredondo-Provecho, Grupo de trabajo equipo multidisciplinar de atención a residencias

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.








![¿Cómo evaluar para la RESP? [PARA REVISORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-revisores-0eaa113abcbc4fc554c7c6c7840ca4c6.jpg)
![¿Cómo recibir avisos sobre nuevos artículos de la RESP? [PARA LECTORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-lectores-aa689338e95aab07df45b4b0d583188f.jpg)

